This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Chinese Academy of Medical Sciences, Hebei Medfaith Pharmaceutical Technology Co., Ltd.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Rongguang Shao: Innovator in Liver Fibrosis Treatment
Introduction
Rongguang Shao is a notable inventor based in Beijing, China. He has made significant contributions to the field of medicine, particularly in the treatment of liver fibrosis. His innovative work has the potential to improve liver health and function.
Latest Patents
Rongguang Shao holds a patent for the use of (benzenesulfonamido) benzamide compounds for inhibiting liver fibrosis. This invention is crucial in the technical field of medicines. It specifically relates to the prevention and treatment of liver injuries and diseases associated with liver fibrosis. The patent focuses on modulating the content of collagen in liver tissue and inhibiting the activity of the COL1A1 promoter in cells.
Career Highlights
Throughout his career, Rongguang Shao has worked with prominent organizations such as Hebei Medfaith Pharmaceutical Technology Co., Ltd. and the Chinese Academy of Medical Sciences. His experience in these institutions has contributed to his expertise in medical innovations.
Collaborations
Rongguang Shao has collaborated with notable colleagues, including Hongwei Tian and Xingang Wang. These partnerships have furthered his research and development efforts in the medical field.
Conclusion
Rongguang Shao is a distinguished inventor whose work in liver fibrosis treatment showcases his commitment to advancing medical science. His innovative patent and collaborations highlight his significant contributions to healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile